Medicared For All Logo

Sead Beganovic MD in Indianapolis, Indiana

Home Indiana Indianapolis

Sead Beganovic MD has Medical Oncology as his primary medical specialty. Their primary office is: 1701 N Senate Blvd in Indianapolis, Indiana.

They're a part of the: Indiana University Health Inc medical group which has around 71 members. You can call their office at 317-962-9000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1979 (around 45 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Sead G Beganovic MD Office Phone and Directions

Sead Beganovic MD
Indiana University Health Inc
1701 N Senate Blvd
Indianapolis, Indiana 46202
317-962-9000


Patient Ratings
Please rate your experience with Sead Beganovic MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 317-962-9000


Enter a starting address:


Healthcare Info for Sead Beganovic MD

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Sead Beganovic MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 5698765238
NPI #: 1821080847
NPI Created On: 08/16/2005
NPI Last Updated Listed as: 01/26/2021
Primary Taxonomy Code: 207RX0202X
License Number:
01057905
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Celtic Insurance Company
  • CareSource
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  2. New patient office or other outpatient visit, typically 60 minutes
  3. Established patient office or other outpatient visit, typically 15 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Established patient office or other outpatient, visit typically 25 minutes
  6. Established patient office or other outpatient, visit typically 40 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 50 minutes per day
  9. Initial hospital inpatient care, typically 70 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Physician telephone patient service, 11-20 minutes of medical discussion
  13. Physician telephone patient service, 21-30 minutes of medical discussion
  14. Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review
  15. Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783692375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812604809

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812604811

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812604813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: SCEMBLIX

Open Associated Drug #1: 0078-1098-20

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819862827

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ALUNBRIG

Open Associated Drug #1: 63020-090-07


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848478751

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: KEYTRUDA

Open Associated Drug #1: 0006-3029-02

Drug or Biological: Biological

Product Category #2: ONCOLOGY

Name Of Drug #2:: LYNPARZA

Associated Drug #2: 0310-0657-58


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848608405

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: KEYTRUDA

Open Associated Drug #1: 0006-3029-02

Drug or Biological: Biological

Product Category #2: ONCOLOGY

Name Of Drug #2:: LYNPARZA

Associated Drug #2: 0310-0657-58


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848702927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: KEYTRUDA

Open Associated Drug #1: 0006-3029-02


Medical Oncology Professionals in Indianapolis

535 Barnhill Dr
Indianapolis, IN
University Medical Diagnostic Associates Inc

6845 Rama Dr
Indianapolis, IN
Indiana University Health Inc

1030 W Michigan St
Indianapolis, IN
Indiana University Health Inc

6845 Rama Dr
Indianapolis, IN
Indiana University Health Inc

550 N University Blvd
Indianapolis, IN
University Medical Diagnostic Associates Inc

7229 Clearvista Dr
Indianapolis, IN
Community Physicians Of Indiana Inc

Providers in Indiana University Health Inc

1.Israa Al-gburi

1701 N Senate Blvd
Indianapolis In 46202-1239
Indiana University Health Inc
Internal Medicine

2.Karam Al-issa

2209 John R Wooden Dr
Martinsville In 46151-1840
Indiana University Health Inc
Hematology/oncology

3.Karam Al-issa

1701 N Senate Ave
Indianapolis In 46202-1239
Indiana University Health Inc
Hematology/oncology

4.Karam Al-issa

1701 N Senate Blvd
Indianapolis In 46202-1239
Indiana University Health Inc
Hematology/oncology

5.Karam Al-issa

1800 N Capitol Ave
Indianapolis In 46202-1239
Indiana University Health Inc
Hematology/oncology

6.Elsayed Aly

1030 W Michigan St
Indianapolis In 46202-5201
Indiana University Health Inc
Medical Oncology

View all 71 members of Indiana University Health Inc medical group